NINGBO SMART PHARMACEUTICAL CO., LTD

Incorporated in 1991, Ningbo Smart Pharmaceutical Co., Ltd (“SMART PHARMA”) is a modern and integrated pharmaceutical manufacturing company that is engaged in research, production and sales of various APIs and intermediates. SMART PHARMA is situated in Ningbo, China on a 20,000m2 land area with convenient transportation links. Among others, the company’s main products include Mefenamic Acid, Diclofenac Sodium, Methocarbamol, Guaifenesin , Mequitazine, Mephenoxalone and Indolinone. With an eye on market demand, SMART PHARMA focuses on both innovation and development strategies, placing great emphasis on the training of its personnel. Led by postdoctoral experts with overseas education backgrounds, the company´s R&D team undertakes the tasks of researching and developing new products and OEM chemical materials. SMART PHARMA has instituted a solid quality management system that overall production and quality management strictly in accordance with the Chinese GMP and ICH Q7A regulations. The Company has obtained the European CEP and EU GMP certification for Diclofenac Sodium, as well as Chinese GMP approval for Mefenamic Acid, Diclofenac Sodium, Methocarbamol and Guaifenesin. Its products sell well in Europe, Japan, Korea, Taiwan, Pakistan, India and Indonesia. SMART PHARMA has established long and stable business relationships with several multinational companies. SMART PHARMA insists on safety and environmental protection first. It strictly abides by national laws and regulation with regards to environmental protection, safety and health, while continuously working towards international standards. It is SMART PHARMA’s aim to forge ahead creatively in keeping with the company’s people-oriented and quality based business objectives, and in an effort to become a leading international brand in the supply of pharmaceutical raw materials.